We are monitoring the impact of COVID-19 on Europe Plasma Fractionation Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2721
Share on
Share on

Europe Plasma Fractionation Market Research Report - By Product (Albumin, Immunoglobulin, Factor VIII, & Protease Inhibitors), Application (Neurology, Hematology, Rheumatology, Pulmonology, & Immunology), End-Users (Hospital & Clinical Laboratories) & By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Size, share, Growth, Trends, & Forecast | 2019 - 2024

Pulished: February, 2020
ID: 2721
Pages: 145

Europe Plasma Fractionation Market Size & Growth (2019-2024):

According to the report, the Europe Plasma Fractionation Market size is valued at USD 5.8 billion in 2019 and is projected to be growing at a CAGR of 6.10%, to touch USD 7.79 billion by 2024 during the forecast period 2019-2024.

Plasma Fractionation consists of screening ad fractionating procedure in which the blood is split into its constituents of the plasma and RBCs, WBCs and platelets. The plasma is studied for various deficiencies and replaced, or treatment is prescribed.

Plasma is a necessary constituent of blood as it constitutes about 55% blood by volume and carries more than a thousand proteins and other substances like electrolytes, hormones that are required for the optimal function of the human body. Albumin is one of the major proteins which is replaced and also used to compensate during plasma exchange.

The growth of the Europe Plasma Fractionation Market is mainly driven by factors such as the increasing incidence of immune and bleeding disorders, the growing incidence of Alpha-1 Antitrypsin deficiency and the rising use of immunoglobulins. Further, an increasingly aging population with related blood-related ailments is set to promote market growth. However, adverse reactions associated with the use of plasma fractionation and transfer, high costs of plasma products and unfavorable reimbursement policies are the major constraints of market growth.

This research report on Europe Plasma Fractionation Market has been segmented and sub-segmented into the following categories and evaluated market size and forecast for each segment until 2024.

  • By Product: Albumin, Immunoglobulin, Factor VIII, and Protease Inhibitors.
  • By Application: Neurology, Haematology, Rheumatology, Pulmonology, and Immunology.
  • By End User: Hospital and Clinical Laboratories.
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Some of the Top Companies leading the Europe Plasma Fractionation Market Profiled in the Report are CSL Ltd. (Australia), Grifols S.A (Spain), Baxalta Incorporated (U.S.), Octapharma AG (Switzerland), Kedrion S.p.A (Italy), Bio Products Laboratory (U.K.), Sanquin (Netherland), China Biologic Products, Inc. (China), Biotest AG (Germany), and Laboratoire Français du Fractionnement et des Biotechnologies (France)

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Fractionation Process         

                                5.1.3 Immunoglobulin   

                                5.1.4 Coagulation Factor Concentrates  

                                5.1.5 Albumin   

                                5.1.6 Protease Inhibitors              

                                5.1.7  Y-o-Y Growth Analysis, By Product              

                                5.1.8  Market Attractiveness Analysis, By Product            

                                5.1.9  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Neurology               

                                5.2.3 Immunology           

                                5.2.4 Hematology            

                                5.2.5 Critical Care             

                                5.2.6 Pulmonology          

                                5.2.7 Hemato-Oncology               

                                5.2.8 Rheumatology       

                                5.2.9 Other Application 

                                5.2.10 Y-o-Y Growth Analysis, By Application      

                                5.2.11 Market Attractiveness Analysis, By Application    

                                5.2.12 Market Share Analysis, By Application      

                5.3 End User                      

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Clinical Laboratories            

                                5.4.4 Academic Institutes            

                                5.4.5 Y-o-Y Growth Analysis, By End User             

                                5.4.6  Market Attractiveness Analysis, By End User          

                                5.4.7  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 U.K                 

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxalta Incorporated                              

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 CSL Ltd.                        

                8.3 Grifols S.A                   

                8.4 Octapharma AG                        

                8.5 Kedrion S.p.A                            

                8.6 Bio Products Laboratory                        

                8.7 Sanquin                        

                8.8 China Biologic Products, Inc.                

                8.9 Biotest AG                  

                8.10 Laboratoire Français du Fractionnement et des Biotechnologies                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Plasma Fractionation Market By Product, From 2019-2024 ( USD Billion )
  2. Europe Immunoglobulin Market By Region, From 2019-2024 ( USD Billion )
  3. Europe Coagulation Factor Concentrates Market By Region, From 2019-2024 ( USD Billion )
  4. Europe Albumin Market By Region, From 2019-2024 ( USD Billion )
  5. Europe Protease Inhibitors Market By Region, From 2019-2024 ( USD Billion )
  6. Europe Other Plasma Products Market By Region, From 2019-2024 ( USD Billion )
  7. Europe Plasma Fractionation Market By Application, From 2019-2024 ( USD Billion )
  8. Europe Neurology Market By Region, From 2019-2024 ( USD Billion )
  9. Europe Immunology Market By Region, From 2019-2024 ( USD Billion )
  10. Europe Hematology Market By Region, From 2019-2024 ( USD Billion )
  11. Europe Critical Care Market By Region, From 2019-2024 ( USD Billion )
  12. Europe Pulmonology Market By Region, From 2019-2024 ( USD Billion )
  13. Europe Hemato-oncology Market By Region, From 2019-2024 ( USD Billion )
  14. Europe Rheumatology Market By Region, From 2019-2024 ( USD Billion )
  15. Europe Other Applications Market By Region, From 2019-2024 ( USD Billion )
  16. Europe Plasma Fractionation Market By By End User, From 2019-2024 ( USD Billion )
  17. Europe Hospitals Market By Region, From 2019-2024 ( USD Billion )
  18. Europe Clinical Laboratories Market By Region, From 2019-2024 ( USD Billion )
  19. Europe Academic Institutes Market By Region, From 2019-2024 ( USD Billion )
  20. U.K. Plasma Fractionation Market By Product, From 2019-2024 ( USD Billion )
  21. U.K. Plasma Fractionation Market By Application, From 2019-2024 ( USD Billion )
  22. U.K. Plasma Fractionation Market By By End User, From 2019-2024 ( USD Billion )
  23. Germany Plasma Fractionation Market By Product, From 2019-2024 ( USD Billion )
  24. Germany Plasma Fractionation Market By Application, From 2019-2024 ( USD Billion )
  25. Germany Plasma Fractionation Market By By End User, From 2019-2024 ( USD Billion )
  26. France Plasma Fractionation Market By Product, From 2019-2024 ( USD Billion )
  27. France Plasma Fractionation Market By Application, From 2019-2024 ( USD Billion )
  28. France Plasma Fractionation Market By By End User, From 2019-2024 ( USD Billion )
  29. Italy Plasma Fractionation Market By Product, From 2019-2024 ( USD Billion )
  30. Italy Plasma Fractionation Market By Application, From 2019-2024 ( USD Billion )
  31. Italy Plasma Fractionation Market By By End User, From 2019-2024 ( USD Billion )
  32. Spain Plasma Fractionation Market By Product, From 2019-2024 ( USD Billion )
  33. Spain Plasma Fractionation Market By Application, From 2019-2024 ( USD Billion )
  34. Spain Plasma Fractionation Market By By End User, From 2019-2024 ( USD Billion )

 

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample